Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA‐E double transgenic pig forelimbs with human blood
暂无分享,去创建一个
E. Wolf | R. Rieben | D. Ayares | N. Klymiuk | A. Bähr | M. Constantinescu | E. Voegelin | J. Seebach | A. Bongoni | D. Kiermeir | H. Jenni
[1] E. Wolf,et al. Activation of the Lectin Pathway of Complement in Pig-to-Human Xenotransplantation Models , 2013, Transplantation.
[2] R. Rieben,et al. Development of a bead‐based multiplex assay for the simultaneous detection of porcine inflammation markers using xMAP technology , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[3] R. Rieben,et al. Ischemia/reperfusion injury of porcine limbs after extracorporeal perfusion. , 2013, The Journal of surgical research.
[4] D. Cooper,et al. Potential benefits and risks of clinical xenotransplantation , 2012 .
[5] R. Bottino,et al. Clinical xenotransplantation: the next medical revolution? , 2012, The Lancet.
[6] H. Niemann,et al. Transgenic expression of human heme oxygenase‐1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys , 2011, Xenotransplantation.
[7] R. Rieben,et al. Preservation of amputated extremities by extracorporeal blood perfusion; a feasibility study in a porcine model. , 2011, The Journal of surgical research.
[8] A. D'apice,et al. The vascular and coagulation issues in xenotransplantation , 2009, Current opinion in organ transplantation.
[9] R. Wanke,et al. HLA-E/Human &bgr;2-Microglobulin Transgenic Pigs: Protection Against Xenogeneic Human Anti-Pig Natural Killer Cell Cytotoxicity , 2009, Transplantation.
[10] John D Lambris,et al. Cytokine Secretion Depends on Galα(1,3)Gal Expression in a Pig-to-Human Whole Blood Model1 , 2008, The Journal of Immunology.
[11] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[12] Mårten K. J. Schneider,et al. Current cellular innate immune hurdles in pig-to-primate xenotransplantation , 2008, Current opinion in organ transplantation.
[13] A. Ganser,et al. Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys , 2008, Xenotransplantation.
[14] R. Pierson,et al. Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here? , 2007, Transplantation.
[15] Dick W. Slaaf,et al. The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.
[16] B. Duling,et al. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. , 2006, American journal of physiology. Heart and circulatory physiology.
[17] Wen-chao Song,et al. Membrane complement regulatory proteins. , 2006, Clinical immunology.
[18] E. Weiss,et al. HLA‐E Expression on Porcine Cells: Protection from Human NK Cytotoxicity Depends on Peptide Loading , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] A. Badley,et al. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] C. Harris,et al. ‘‘Homologous restriction’’ in complement lysis: roles of membrane complement regulators , 2005, Xenotransplantation.
[21] B. Loveland,et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non‐immunosuppressed baboons , 2004, Xenotransplantation.
[22] R. Biassoni,et al. Human Natural Killer cell receptors: insights into their molecular function and structure , 2003, Journal of cellular and molecular medicine.
[23] S. H. A. Chen,et al. Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.
[24] J. Platt,et al. The immunological barrier to xenotransplantation. , 2001, Immunity.
[25] J. Platt,et al. A HUMAN CD46 TRANSGENIC PIG MODEL SYSTEM FOR THE STUDY OF DISCORDANT XENOTRANSPLANTATION , 2001, Transplantation.
[26] Y. Gruel,et al. Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions. , 2000, Surgery.
[27] C. Mold,et al. Cooperation between decay accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack , 2000 .
[28] J. Platt,et al. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha. , 2000, Circulation.
[29] T. Mohanakumar,et al. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. , 1999, Journal of immunology.
[30] G. Remuzzi,et al. Xenogeneic serum promotes leukocyte-endothelium interaction under flow through two temporally distinct pathways: role of complement and nuclear factor-kappaB. , 1999, Journal of the American Society of Nephrology : JASN.
[31] J. Torras,et al. Hyperacute rejection models: ex vivo xenoperfusion systems. , 1999, Transplantation proceedings.
[32] M. Llano,et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Platt,et al. Induction of procoagulant function in porcine endothelial cells by human natural killer cells. , 1997, Journal of immunology.
[34] D. Sachs,et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. , 1997, Journal of immunology.
[35] D H Sachs,et al. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. , 1997, Journal of immunology.
[36] M. S. Williams,et al. Do CTL kill target cells by inducing apoptosis? , 1997, Seminars in immunology.
[37] J. Platt,et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. , 1997, Transplantation.
[38] J. Platt,et al. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: Evidence for proteolysis of cell‐surface molecules , 1996, Journal of cellular physiology.
[39] B. Loveland,et al. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro , 1996, European journal of immunology.
[40] D. White,et al. The generation of transgenic pigs as potential organ donors for humans , 1995, Nature Medicine.
[41] R. Pardi,et al. Early Events in Cell‐Mediated Recognition of Vascularized Xenografts: Cooperative Interactions between Selected Lymphocyte Subsets and Natural Antibodies , 1994, Immunological reviews.
[42] R. Johnstone,et al. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. , 1993, Transplant immunology.
[43] J. Platt,et al. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. , 1991, Transplantation.
[44] J. Platt,et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. , 1991, Transplantation.
[45] V. Nussenzweig,et al. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. , 1986, Journal of immunology.
[46] R. Colvin,et al. Cardiovascular , Pulmonary and Renal Pathology Thrombotic Microangiopathy Associated with Humoral Rejection of Cardiac Xenografts from 1 , 3-Galactosyltransferase Gene-Knockout Pigs in Baboons , 2010 .
[47] M. Okabe,et al. Complement regulation in the GalT KO era , 2010, Xenotransplantation.
[48] R. Rieben,et al. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. , 2005, Trends in immunology.
[49] N. Mueller,et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.
[50] D. Sachs,et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue , 2005, Nature Medicine.
[51] T. Starzl,et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.
[52] M. Suckfüll,et al. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. , 1994, Transplantation.